BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36555584)

  • 1. Pharmacological Agents with Antiviral Activity against Monkeypox Infection.
    Zovi A; Ferrara F; Langella R; Vitiello A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses.
    Wang J; Shahed-Ai-Mahmud M; Chen A; Li K; Tan H; Joyce R
    J Med Chem; 2023 Apr; 66(7):4468-4490. PubMed ID: 36961984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.
    Soheili M; Nasseri S; Afraie M; Khateri S; Moradi Y; Mahdavi Mortazavi SM; Gilzad-Kohan H
    J Pharm Pharm Sci; 2022; 25():297-322. PubMed ID: 36130588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.
    Karagoz A; Tombuloglu H; Alsaeed M; Tombuloglu G; AlRubaish AA; Mahmoud A; Smajlović S; Ćordić S; Rabaan AA; Alsuhaimi E
    J Infect Public Health; 2023 Apr; 16(4):531-541. PubMed ID: 36801633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and Treatment of Monkeypox.
    Rizk JG; Lippi G; Henry BM; Forthal DN; Rizk Y
    Drugs; 2022 Jun; 82(9):957-963. PubMed ID: 35763248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-emerging human monkeypox: A major public-health debacle.
    Saxena SK; Ansari S; Maurya VK; Kumar S; Jain A; Paweska JT; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2023 Jan; 95(1):e27902. PubMed ID: 35652133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monkeypox infection: The past, present, and future.
    Upadhayay S; Arthur R; Soni D; Yadav P; Navik U; Singh R; Gurjeet Singh T; Kumar P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109382. PubMed ID: 36330915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies.
    Rabaan AA; Abas AH; Tallei TE; Al-Zaher MA; Al-Sheef NM; Fatimawali ; Al-Nass EZ; Al-Ebrahim EA; Effendi Y; Idroes R; Alhabib MF; Al-Fheid HA; Adam AA; Bin Emran T
    J Med Virol; 2023 Jan; 95(1):e28306. PubMed ID: 36372558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2022 human monkeypox outbreak: Clinical review and management guidance.
    Aldhaeefi M; Rungkitwattanakul D; Unonu J; Franklin CJ; Lyons J; Hager K; Daftary MN
    Am J Health Syst Pharm; 2023 Jan; 80(2):44-52. PubMed ID: 36259674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries.
    Quarleri J; Delpino MV; Galvan V
    Geroscience; 2022 Aug; 44(4):2095-2103. PubMed ID: 35726117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
    Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks.
    Islam MR; Hossain MJ; Roy A; Hasan AHMN; Rahman MA; Shahriar M; Bhuiyan MA
    Health Sci Rep; 2022 Sep; 5(5):e798. PubMed ID: 36032515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.
    Smith SK; Self J; Weiss S; Carroll D; Braden Z; Regnery RL; Davidson W; Jordan R; Hruby DE; Damon IK
    J Virol; 2011 Sep; 85(17):9176-87. PubMed ID: 21697474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of Monkeypox Virus Disease: An Update on Epidemiology, Pathophysiology and Available Treatment Options.
    Kumar A; Angaria N; Singh G; Kumar R
    Infect Disord Drug Targets; 2023; 23(6):e180423216001. PubMed ID: 37073653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparedness for a monkeypox outbreak.
    Luo Q; Han J
    Infect Med (Beijing); 2022 Jun; 1(2):124-134. PubMed ID: 38013719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monkeypox: What do we know so far? A short narrative review of literature.
    Deshmukh P; Vora A; Tiwaskar M; Joshi S
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monkeypox infection threat: A comprehensive overview.
    Kang Y; Yu Y; Xu S
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011246. PubMed ID: 37079486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
    Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monkeypox - After 40 years, an unintended consequence of smallpox eradication.
    Shah HH; Molani MK; Shabbir N
    Front Public Health; 2022; 10():1082586. PubMed ID: 36684902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
    Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
    J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.